165 related articles for article (PubMed ID: 26661560)
1. Rapid resolution of cardiac rhabdomyomas following everolimus therapy.
Choudhry S; Nguyen HH; Anwar S
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26661560
[TBL] [Abstract][Full Text] [Related]
2. Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex.
Goyer I; Dahdah N; Major P
Pediatr Neurol; 2015 Apr; 52(4):450-3. PubMed ID: 25682485
[TBL] [Abstract][Full Text] [Related]
3. Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.
Doğan V; Yeşil Ş; Kayalı Ş; Beken S; Özgür S; Ertuğrul İ; Bozkurt C; Örün UA; Karademir S
J Trop Pediatr; 2015 Feb; 61(1):74-7. PubMed ID: 25344617
[TBL] [Abstract][Full Text] [Related]
4. Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia.
Öztunç F; Atik SU; Güneş AO
Cardiol Young; 2015 Oct; 25(7):1411-4. PubMed ID: 26339757
[TBL] [Abstract][Full Text] [Related]
5. Regression of a cardiac rhabdomyoma in a patient receiving everolimus.
Tiberio D; Franz DN; Phillips JR
Pediatrics; 2011 May; 127(5):e1335-7. PubMed ID: 21464184
[TBL] [Abstract][Full Text] [Related]
6. Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex.
Colaneri M; Quarti A; Pozzi M
Cardiol Young; 2016 Jun; 26(5):1025-8. PubMed ID: 27055516
[TBL] [Abstract][Full Text] [Related]
7. Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature.
Martínez-García A; Michel-Macías C; Cordero-González G; Escamilla-Sánchez KI; Aguinaga-Ríos M; Coronado-Zarco A; Cardona-Pérez JA
Cardiol Young; 2018 Jul; 28(7):903-909. PubMed ID: 29759095
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus.
Mlczoch E; Hanslik A; Luckner D; Kitzmüller E; Prayer D; Michel-Behnke I
Ultrasound Obstet Gynecol; 2015 May; 45(5):618-21. PubMed ID: 24913039
[TBL] [Abstract][Full Text] [Related]
9. Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex.
Aw F; Goyer I; Raboisson MJ; Boutin C; Major P; Dahdah N
Pediatr Cardiol; 2017 Feb; 38(2):394-400. PubMed ID: 27878332
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Rhabdomyomas in Tuberous Sclerosis Complex.
Castro-Monsalve J; Alvarado-Socarras JL; Mantilla KA; Forero L; Moreno A; Prada CE
J Pediatr; 2018 Jan; 192():264-264.e1. PubMed ID: 29128117
[No Abstract] [Full Text] [Related]
11. Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect.
Mohamed I; Ethier G; Goyer I; Major P; Dahdah N
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25427930
[TBL] [Abstract][Full Text] [Related]
12. Long-term use of everolimus for refractory arrhythmia in a child with tuberous sclerosis complex.
Hofmann C; Syrbe S; Hebe J; Kreft J; Stark S; Milde T; Völkers M; Hoffmann GF; Gorenflo M; Kovacevic A
Am J Med Genet A; 2024 May; 194(5):e63508. PubMed ID: 38130096
[TBL] [Abstract][Full Text] [Related]
13. Rapid regression of large cardiac rhabdomyomas in neonates after sirolimus therapy.
Weiland MD; Bonello K; Hill KD
Cardiol Young; 2018 Mar; 28(3):485-489. PubMed ID: 29233209
[TBL] [Abstract][Full Text] [Related]
14. Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma.
Demir HA; Ekici F; Yazal Erdem A; Emir S; Tunç B
Pediatrics; 2012 Jul; 130(1):e243-7. PubMed ID: 22732179
[TBL] [Abstract][Full Text] [Related]
15. Everolimus for the Treatment of Tuberous Sclerosis Complex-Related Cardiac Rhabdomyomas in Pediatric Patients.
Dahdah N
J Pediatr; 2017 Nov; 190():21-26.e7. PubMed ID: 28888564
[No Abstract] [Full Text] [Related]
16. Cardiac Rhabdomyomas Presenting with Critical Cardiac Obstruction in Neonates and Infants: Treatment Strategies and Outcome, A Single-Center Experience.
Ng LY; McGuinness J; Prendiville T; Franklin O; Walsh M; Kenny D; Nolke L; McMahon CJ
Pediatr Cardiol; 2024 Jun; 45(5):1132-1141. PubMed ID: 38480570
[TBL] [Abstract][Full Text] [Related]
17. Regression of Neonatal Cardiac Rhabdomyoma in Two Months Through Low-Dose Everolimus Therapy: A Report of Three Cases.
Chang JS; Chiou PY; Yao SH; Chou IC; Lin CY
Pediatr Cardiol; 2017 Oct; 38(7):1478-1484. PubMed ID: 28780710
[TBL] [Abstract][Full Text] [Related]
18. Cardiac rhabdomyomas in tuberous sclerosis patients: a case report and review of the literature.
Benyounes N; Fohlen M; Devys JM; Delalande O; Moures JM; Cohen A
Arch Cardiovasc Dis; 2012; 105(8-9):442-5. PubMed ID: 22958887
[TBL] [Abstract][Full Text] [Related]
19. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
MacKeigan JP; Krueger DA
Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
[TBL] [Abstract][Full Text] [Related]
20. New-onset cardiac rhabdomyoma beyond infancy in a patient with tuberous sclerosis complex.
Thatte NM; Guleserian KJ; Veeram Reddy SR
Cardiol Young; 2016 Feb; 26(2):396-9. PubMed ID: 26169191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
